Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant

NCT07050160 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Lexeo Therapeutics